Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts

Acta Odontologica Scandinavica

Volumn 72, Issue 5, 2014, Pages 337-345

  Andrukhov, Oleh ^a   Ertlschweiger, Sandra ^a   Moritz, Andreas ^a   Bantleon, Hans Peter ^a   Rausch Fan, Xiaohui ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokines; Innate immune response; Pattern recognition receptors; Periodontal disease

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; O ANTIGEN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ESCHERICHIA COLI; FIBROBLAST; GENETICS; GINGIVA; HUMAN; IMMUNOLOGY; METABOLISM; PORPHYROMONAS GINGIVALIS; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; ESCHERICHIA COLI; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-6; O ANTIGENS; PORPHYROMONAS GINGIVALIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 84903181977     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016357.2013.834535     Document Type: Article

References (43)

1. Jenkinson HF, Dymock D. The microbiology of periodontal disease. Dent Update 1999;26:191-7.
2. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23:301-4.
3. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
4. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev 2004;4:499-511.
5. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5: 78-111.
6. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001;69:1477-82.
7. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001;167:5278-85.
8. Coats SR, Reife RA, Bainbridge BW, Pham TT, Darveau RP. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun 2003;71:6799-807.
9. Herath TD, Darveau RP, Seneviratne CJ, Wang CY, Wang Y, Jin L. Tetra-and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB signal transduction cascade and immune-inflammatory response in human gingival fibroblasts. PLoS ONE 2013;8:e58496.
10. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72:5041-51.
11. Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993;3:9-38.
12. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med 2002;13:132-42.
13. Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 2007; 43:41-55.
14. Wang PL, Oido-Mori M, Fujii T, Kowashi Y, Kikuchi M, Suetsugu Y, et al. Heterogeneous expression of Toll-like receptor 4 and downregulation of Toll-like receptor 4 expression on human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide. Biochem Biophys Res Commun 2001;288:863-7.
15. Hatakeyama J, Tamai R, Sugiyama A, Akashi S, Sugawara S, Takada H. Contrasting responses of human gingival and periodontal ligament fibroblasts to bacterial cell-surface components through the CD14/Toll-like receptor system. Oral Microbiol Immunol 2003;18:14-23.
16. Asai Y, Hashimoto M, Fletcher HM, Miyake K, Akira S, Ogawa T. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect Immun 2005;73:2157-63.
17. Sugawara S, Sugiyama A, Nemoto E, Rikiishi H, Takada H. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun 1998;66:3043-9.
18. Scheres N, Laine ML, de Vries TJ, Everts V, van Winkelhoff AJ. Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. J Periodontal Res 2010;45:262-70.
19. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000;165:618-22.
20. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 2009;88:741-5.
21. Sekot G, Posch G, Messner P, Matejka M, Rausch-Fan X, Andrukhov O, et al. Potential of the Tannerella forsythia S-layer to delay the immune response. J Dent Res 2011;90: 109-14.
22. Roberts FA, Richardson GJ, Michalek SM. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun 1997;65: 3248-54.
23. Nebel D, Arvidsson J, Lillqvist J, Holm A, Nilsson BO. Differential effects of LPS from Escherichia coli and Porphyromonas gingivalis on IL-6 production in human periodontal ligament cells. Acta Odontol Scand 2013;71:892-8.
24. Diya Z, Lili C, Shenglai L, Zhiyuan G, Jie Y. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 2008;14:99-107.
25. Morandini AC, Chaves Souza PP, Ramos-Junior ES, Brozoski DT, Sipert CR, Souza Costa CA, et al. Toll-like receptor 2 knockdown modulates interleukin (IL)-6 and IL-8-but not Stromal Derived Factor-1 (SDF-1/CXCL12) in human periodontal ligament and gingival fibroblasts. J Periodontol 2012;84:535-44.
26. Ogawa T. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Letts 1993; 332:197-201.
27. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001;167:5067-76.
28. Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J, Michalek SM. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 2003;171: 717-25.
29. Reife RA, Coats SR, Al-Qutub M, Dixon DM, Braham PA, Billharz RJ, et al. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra-and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol 2006;8:857-68.
30. Herath TD, Wang Y, Seneviratne CJ, Lu Q, Darveau RP, Wang CY, et al. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity differentially modulates the expression of IL-6 and IL-8 in human gingival fibroblasts. J Clin Periodontol 2011;38:694-701.
31. Zhou J, Windsor LJ. Heterogeneity in the collagen-degrading ability of Porphyromonas gingivalis-stimulated human gingival fibroblasts. J Periodontal Res 2007;42:77-84.
32. Almasri A, Wisithphrom K, Windsor LJ, Olson B. Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts. J Periodontol 2007;78:533-41.
33. Yokoyama M, Hinode D, Masuda K, Yoshioka M, Grenier D. Effect of female sex hormones on Campylobacter rectus and human gingival fibroblasts. Oral Microbiol Immunol 2005;20:239-43.
34. Lapp CA, Lapp DF. Analysis of interleukin-activated human gingival fibroblasts: modulation of chemokine responses by female hormones. J Periodontol 2005;76:803-12.
35. Lorenz E. TLR2 and. TLR4 expression during bacterial infections. Curr Pharm Des 2006;12:4185-93.
36. Kawai T, Akira S. TLR signaling. Sem Immunol 2007;19: 24-32.
37. Liew FY, Xu D, Brint EK, O?Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev 2005; 5:446-58.
38. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003;82:82-90.
39. Tabeta K, Yamazaki K, Akashi S, Miyake K, Kumada H, Umemoto T, et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 2000;68: 3731-5.
40. Wara-Aswapati N, Chayasadom A, Surarit R, Pitiphat W, Boch JA, Nagasawa T, et al. Induction of Toll-like receptor expression by porphyromonas gingivalis. J Periodontol 2012; 84:1010-18.
41. Ren L, Leung WK, Loo TW, Jin L. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast. J Periodontal Res 2005;40:407-16.
42. Scheres N, Laine ML, Sipos PM, Bosch-Tijhof CJ, Crielaard W, de Vries TJ, et al. Periodontal ligament and gingival fibroblasts from periodontitis patients are more active in interaction with Porphyromonas gingivalis. J Periodontal Res 2011;46:407-16.
43. Chen XM, Splinter PL, O?Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulatesToll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvuminfection. J Biol Chem 2007;282:28929-38.